SAFETY, AND TOLERABILITY
Clinical trials for SAFETY, AND TOLERABILITY explained in plain language.
Never miss a new study
Get alerted when new SAFETY, AND TOLERABILITY trials appear
Sign up with your email to follow new studies for SAFETY, AND TOLERABILITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Healthy volunteers test drug interaction in Early-Stage trial
Knowledge-focused CompletedThis early-stage trial looked at how a new medicine for acid reflux (linaprazan glurate) affects the way the body processes the common antibiotic amoxicillin. Twelve healthy adults took both drugs and had their blood levels measured. The goal was to gather safety and drug interac…
Matched conditions: SAFETY, AND TOLERABILITY
Phase: PHASE1 • Sponsor: Cinclus Pharma Holding AB • Aim: Knowledge-focused
Last updated May 26, 2026 08:32 UTC
-
Migraine drug gets a breath of fresh air: inhaler version tested
Knowledge-focused CompletedThis early-stage study tested a new inhaled powder form of the migraine drug dihydroergotamine (DHE) in 44 healthy adults. Researchers compared how the body absorbs the drug when given as an inhaled powder, an injection, or a nasal spray. The goal was to measure safety and how we…
Matched conditions: SAFETY, AND TOLERABILITY
Phase: PHASE1 • Sponsor: Aspeya Switzerland SA • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
New antibody AK1967 tested in healthy men for first time
Knowledge-focused CompletedThis early-phase study tested a new antibody called AK1967 (Procizumab) in 24 healthy men to see if it is safe and how the body processes it. The antibody targets a protein that may worsen heart shock. This is a first step before testing it in patients with heart problems.
Matched conditions: SAFETY, AND TOLERABILITY
Phase: PHASE1 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC